Bologna, Italy

Anna Minarini


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Minarini: Innovator in Topoisomerase II Inhibitors

Introduction

Anna Minarini is a notable inventor based in Bologna, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target cancer treatment. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Anna Minarini holds a patent for "4-amino-2-pyrido-bicyclic pyrimidines and use thereof as topoisomerase II inhibitors." This invention concerns 4-amino-2-pyrido-bicyclic pyrimidines of Formula (I) that function as type II topoisomerase inhibitors. These compounds are particularly valuable as medicaments in the treatment of cancer. The patent also outlines a method for the manufacture of these compounds, highlighting their potential therapeutic applications.

Career Highlights

Throughout her career, Anna Minarini has worked with prestigious institutions, including the Università Degli Studi Di Padova and Alma Mater Studiorum - Università Di Bologna. Her academic and research endeavors have positioned her as a key figure in her field, contributing to the advancement of cancer treatment methodologies.

Collaborations

Anna has collaborated with esteemed colleagues such as Marco De Vivo and Jose Antonio Ortega Martinez. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Anna Minarini's work exemplifies the intersection of innovation and medical science. Her contributions to the development of topoisomerase II inhibitors represent a significant advancement in cancer treatment. Through her patents and collaborations, she continues to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…